Agarwal Arjun
Senior Vice President, Finance · 22 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | Sale | 5,656 | $84.90 | $480,201.19 | filing |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | Sale | 3,743 | $84.26 | $315,369.09 | filing |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | Option exercise | 8,541 | $12.50 | $106,762.50 | filing |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | Option exercise | 1,458 | $34.39 | $50,140.62 | filing |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | Sale | 300 | $85.63 | $25,689.99 | filing |
| 2026-07-13 | ORKA | Oruka Therapeutics, Inc. | Sale | 300 | $83.07 | $24,919.95 | filing |
| 2026-06-22 | ORKA | Oruka Therapeutics, Inc. | Sale | 888 | $80.01 | $71,048.88 | filing |
| 2026-06-22 | ORKA | Oruka Therapeutics, Inc. | Sale | 699 | $82.15 | $57,419.36 | filing |
| 2026-06-15 | ORKA | Oruka Therapeutics, Inc. | Sale | 395 | $69.69 | $27,527.55 | filing |
| 2026-06-12 | ORKA | Oruka Therapeutics, Inc. | Sale | 4,340 | $69.85 | $303,154.21 | filing |
| 2026-06-12 | ORKA | Oruka Therapeutics, Inc. | Sale | 3,260 | $70.34 | $229,305.79 | filing |
| 2026-06-12 | ORKA | Oruka Therapeutics, Inc. | Sale | 1,859 | $68.34 | $127,047.59 | filing |
| 2026-06-12 | ORKA | Oruka Therapeutics, Inc. | Option exercise | 8,000 | $12.50 | $100,000.00 | filing |
| 2026-06-12 | ORKA | Oruka Therapeutics, Inc. | Option exercise | 1,459 | $34.39 | $50,175.01 | filing |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | Sale | 4,600 | $59.19 | $272,259.74 | filing |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | Sale | 4,190 | $58.34 | $244,465.13 | filing |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | Option exercise | 5,833 | $34.39 | $200,596.87 | filing |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | Sale | 800 | $60.34 | $48,269.12 | filing |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | Sale | 700 | $61.16 | $42,812.42 | filing |
| 2026-05-18 | ORKA | Oruka Therapeutics, Inc. | Option exercise | 2,000 | $12.50 | $25,000.00 | filing |
| 2026-03-16 | ORKA | Oruka Therapeutics, Inc. | Sale | 395 | $41.30 | $16,313.50 | filing |
| 2026-01-23 | ORKA | Oruka Therapeutics, Inc. | Award | 17,500 | $0.00 | $0.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.